Cyclic Peptide [R(4)W(4)] in Improving the Ability of First-Line Antibiotics to Inhibit Mycobacterium tuberculosis Inside in vitro Human Granulomas

Tuberculosis (TB) is currently one of the leading causes of global mortality. Medical non-compliance due to the length of the treatment and antibiotic side effects has led to the emergence of multidrug-resistant (MDR) strains of Mycobacterium tuberculosis (M. tb) that are difficult to treat. A curre...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez, Joshua, Ashley, David, Cao, Ruoqiong, Abrahem, Rachel, Nguyen, Timothy, To, Kimberly, Yegiazaryan, Aram, Akinwale David, Ajayi, Kumar Tiwari, Rakesh, Venketaraman, Vishwanath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438584/
https://www.ncbi.nlm.nih.gov/pubmed/32973740
http://dx.doi.org/10.3389/fimmu.2020.01677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438584/
https://www.ncbi.nlm.nih.gov/pubmed/32973740
http://dx.doi.org/10.3389/fimmu.2020.01677

Ejemplares similares